Aclaris Therapeutics, Inc.（ACRS）内部人交易：高管与董事近期交易
过去 18 个月，共有 13 位内部人为 Aclaris Therapeutics, Inc.（ACRS）报告了 49 笔 Form 4 交易（最近一笔 2026-08-04）。
| 日期 | 内部人 | 职务 | 类型 | 股数 | 市值 |
|---|---|---|---|---|---|
| 2026-08-04 | Kolbeck Roland Wilhelm | Chief Scientific Officer | 买入 | 36,375 | $0 |
| 2026-08-04 | Kolbeck Roland Wilhelm | Chief Scientific Officer | 卖出 | 12,385 | $64,402 |
| 2026-06-08 | GOWEN MAXINE | 董事 | 买入 | 11,580 | $0 |
| 2026-06-08 | Mehra Anand | 董事 | 买入 | 11,580 | $0 |
| 2026-06-08 | MILANO VINCENT | 董事 | 买入 | 11,580 | $0 |
| 2026-06-08 | Molineaux Christopher P. | 董事 | 买入 | 11,580 | $0 |
| 2026-06-08 | SCHIFF ANDREW N | 董事 | 买入 | 11,580 | $0 |
| 2026-06-08 | Humphries William D. | 董事 | 买入 | 11,580 | $0 |
| 2026-05-05 | Hall Jesse Wayne | Chief Medical Officer | 买入 | 36,375 | $0 |
| 2026-05-05 | Hall Jesse Wayne | Chief Medical Officer | 卖出 | 9,330 | $41,145 |
| 2026-04-27 | Leonard Braden Michael | 10% 以上股东 | 卖出 | 300,000 | $1.4M |
| 2026-03-03 | Balthaser Kevin | Chief Financial Officer | 买入 | 2,375 | $0 |
| 2026-03-03 | Balthaser Kevin | Chief Financial Officer | 卖出 | 677 | $1,943 |
| 2026-02-05 | Loerop James | Chief Business Officer | 买入 | 11,250 | $0 |
| 2026-02-05 | Loerop James | Chief Business Officer | 买入 | 20,875 | $0 |
| 2026-02-05 | Loerop James | Chief Business Officer | 卖出 | 5,937 | $20,601 |
| 2026-02-05 | Walker Neal | CEO | 买入 | 63,475 | $0 |
| 2026-02-05 | Walker Neal | CEO | 卖出 | 18,611 | $64,580 |
| 2026-02-05 | Balthaser Kevin | Chief Financial Officer | 买入 | 22,025 | $0 |
| 2026-02-05 | Balthaser Kevin | Chief Financial Officer | 卖出 | 6,449 | $22,378 |
| 2026-02-05 | Davis Hugh M. | President and COO | 买入 | 18,675 | $0 |
| 2026-02-05 | Loerop James | Chief Business Officer | 买入 | 7,500 | $0 |
| 2026-02-05 | Loerop James | Chief Business Officer | 买入 | 14,750 | $0 |
| 2026-02-05 | Loerop James | Chief Business Officer | 卖出 | 10,686 | $37,508 |
| 2026-02-03 | Balthaser Kevin | Chief Financial Officer | 买入 | 14,750 | $0 |
来源：SEC Form 4 申报文件 · 截至 2026-08-04